Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Capital Expenditures (2022 - 2026)

Updated

Context Therapeutics' Capital Expenditures was $18,488 in Q2 2026, down 50.4% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Capital Expenditures (2022 - 2026) Analysis & Trends

For FY2025, Capital Expenditures at Context Therapeutics came in at $33,948, up 364.0% from FY2024.

  • Capital Expenditures shows a three-year compound annual growth rate of -2.7% (FY2022 to FY2025).
  • In earlier years, Capital Expenditures was $7,316 in FY2024 and $36,836 in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Capital Expenditures since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -39,045.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 3.18 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 1.36 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 301.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 1.04 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 237.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18,488.00
Mar 31, 2026 37,258.00
Mar 31, 2025 33,948.00
Sep 30, 2024 7,316.00
Jun 30, 2022 1,837.00
Mar 31, 2022 34,999.00
API Access

Context Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CNTX&period=max&api_key=YOUR_API_KEY